[HTML][HTML] Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence
C Wagner, M Griesel, A Mikolajewska… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
[HTML][HTML] Preliminary guidelines for the clinical evaluation and management of long COVID
Y Kim, SE Kim, T Kim, KW Yun, SH Lee… - Infection & …, 2022 - ncbi.nlm.nih.gov
Long-lasting coronavirus disease 2019 (COVID-19) symptoms beyond 12 weeks, the so-
called 'long COVID'have been increasingly reported worldwide. Long COVID can be …
called 'long COVID'have been increasingly reported worldwide. Long COVID can be …
Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …
global attention. However, basic epidemiologic characteristics have not firmly been …
Systemic corticosteroids for the treatment of COVID‐19
Cochrane Haematology Group… - Cochrane Database …, 1996 - cochranelibrary.com
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
Serum iron indices in COVID‐19‐associated mucormycosis: a case–control study
Background Whether dysregulated iron metabolism is associated with COVID‐19‐
associated mucormycosis (CAM) remains unknown. Herein, we compare the serum iron …
associated mucormycosis (CAM) remains unknown. Herein, we compare the serum iron …
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review
M Faiyazuddin, A Sophia, S Ashique… - Frontiers in …, 2023 - frontiersin.org
The outbreak of a fatal black fungus infection after the resurgence of the cadaverous COVID-
19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new …
19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new …
Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis
LC García-Carnero, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …
mortality and morbidity among patients with comorbidities. This viral infection promotes the …
Epidemiology of COVID-19–associated mucormycosis
K Tayabali, H Pothiwalla, S Narayanan - Current Fungal Infection Reports, 2023 - Springer
Abstract Purpose of the Review To describe the epidemiology and risk factors for
Coronavirus disease-19 (COVID-19)–associated mucormycosis (CAM) based on current …
Coronavirus disease-19 (COVID-19)–associated mucormycosis (CAM) based on current …
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
M Ponnaiah, S Ganesan, T Bhatnagar… - PLoS …, 2022 - journals.plos.org
Background In the ongoing COVID-19 pandemic, an increased incidence of ROCM was
noted in India among those infected with COVID. We determined risk factors for rhino-orbito …
noted in India among those infected with COVID. We determined risk factors for rhino-orbito …
Mucormycosis in COVID-19 patients: predisposing factors, prevention and management
PK Rudrabhatla, A Reghukumar, SV Thomas - Acta Neurologica Belgica, 2022 - Springer
India is considered the diabetes capital of the world and has the highest burden of
mucormycosis. Bacterial, viral and fungal co-infections are increasingly being reported in …
mucormycosis. Bacterial, viral and fungal co-infections are increasingly being reported in …